Skip to main content

Overview of Type 1 and Type 2 AIP

  • Chapter
  • First Online:
Autoimmune Pancreatitis

Abstract

Autoimmune pancreatitis (AIP) is a peculiar form of pancreatitis that has been known for the last two decades. Sarles et al. [1] first reported pancreatitis associated with hypergammaglobulinemia in 1961. They suggested that autoimmunity was one of the etiologies of pancreatitis. The first case that led researchers to suggest a new concept of autoimmune pancreatitis (AIP) was treated with steroids by gastroenterologists (led by Professor Tadashi Takeuchi) in Tokyo Medical Women’s University, and the concept was proposed by Yoshida, a member of that group, in 1995 [2]. The characteristic histological feature of the AIP is lymphoplasmacytic sclerosing pancreatitis (LPSP) [3]. AIP has been increasingly seen over the last decade and is now considered a distinct entity [4, 5]. Based on histological and immunohistochemical examinations of various organs and extrapancreatic lesions of AIP patients, a new clinicopathological entity called “IgG4-related systemic disease” was proposed [4, 6]. AIP is now considered to be a pancreatic manifestation of IgG4-related disease [4, 5, 7].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sarles H, Sarles JC, Muratoren R, Guien C. Chronic inflammatory sclerosing of the pancreas–an autonomous pancreatic disease? Am J Dig Dis. 1961;6:688–98.

    Article  CAS  PubMed  Google Scholar 

  2. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561–8.

    Article  CAS  PubMed  Google Scholar 

  3. Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tsuruta K, Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol. 1991;22:387–95.

    Article  CAS  PubMed  Google Scholar 

  4. Kamisawa T, Takuma K, Egawa N, Tsuruta K, Sasaki T. Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol. 2010;7:401–9.

    Article  CAS  PubMed  Google Scholar 

  5. Kamisawa T, Chari ST, Lerch MM, Kim MH, Gress TM, Shimosegawa T. Recent advances in autoimmune pancreatitis: type 1 and type 2. Gut. 2013;62:1373–80.

    Google Scholar 

  6. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38:982–4.

    Article  CAS  PubMed  Google Scholar 

  7. Stone JH, Khosroshani A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64:3061–7.

    Article  CAS  PubMed  Google Scholar 

  8. Notohara K, Burgart LJ, Yadav D, Chari S, Smyrk TC. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration. Clinicopathologic features of 35 cases. Am J Surg Patho. 2003;27:1119–27.

    Article  Google Scholar 

  9. Zamboni G, Luttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virch Arch. 2004;445:552–63.

    Article  Google Scholar 

  10. Chari ST, Kloeppel G, Zhang L, et al. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreatology. 2010;10:664–72.

    Article  PubMed  Google Scholar 

  11. Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology. 2010;139:140–8.

    Article  PubMed  Google Scholar 

  12. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.

    Article  CAS  PubMed  Google Scholar 

  13. Members of the Criteria Committee for Autoimmune Pancreatitis of the Japan Pancreas Society. Diagnostic criteria for autoimmune pancreatitis by the Japan Pancreas Society (in Japanese). Suizou. 2002;17:585–7.

    Google Scholar 

  14. Chari ST, Smyrk TC, Levy MJ, et al. Autoimmune pancreatitis: diagnosis using histology, imaging, serology, other organ involvement and response to steroids. Clin Gastroenterol Hepatol. 2006;4:1010–6.

    Article  PubMed  Google Scholar 

  15. Kim KP, Kim MH, Kim JC, et al. Diagnostic criteria for autoimmune chronic pancreatitis revised. World J Gastroenterol. 2006;12:2487–96.

    PubMed Central  PubMed  Google Scholar 

  16. Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea symposium on autoimmune pancreatitis. J Gastroenterol. 2008;43:403–8.

    Article  CAS  PubMed  Google Scholar 

  17. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut. 2009;58:1504–7.

    Article  CAS  PubMed  Google Scholar 

  18. Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352–8.

    Article  PubMed  Google Scholar 

  19. Kamisawa T, Chari ST, Giday SA, et al. Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas. 2011;40:352–8.

    Article  PubMed  Google Scholar 

  20. Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 2012;62:1771–6.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Kanno A, Nishimori I, Masamune A, et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan. Pancreas. 2011;41:835–9.

    Article  Google Scholar 

  22. Chari ST, Takahashi N, Levy MJ, et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol. 2009;7:1097–103.

    Article  CAS  PubMed  Google Scholar 

  23. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol. 2008;14:3948–55.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Kamisawa T, Egawa N, Inokuma S, et al. Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy. Pancreas. 2003;27:235–8.

    Article  CAS  PubMed  Google Scholar 

  25. Miyamoto Y, Kamisawa T, Tabata T, et al. Short and long-term outcomes of diabetes mellitus in patients with autoimmune pancreatitis after steroid therapy. Gut Liver. 2012;6:501–4.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Kamisawa T, Anjiki H, Egawa N, Kubota N. Allergic manifestations in autoimmune pancreatitis. Eur J Gastroenterol Hepatol. 2009;21:1136–9.

    Article  PubMed  Google Scholar 

  27. Tabata T, Kamisawa T, Takuma K, et al. Serum IgG4 concentrations and IgG4-related sclerosing disease. Clin Chim Acta. 2009;408:25–8.

    Article  CAS  PubMed  Google Scholar 

  28. Ryu JK, Chung JB, Park SW, et al. Review of 67 patients with autoimmune pancreatitis in Korea. A multicenter nationwide study. Pancreas. 2008;37:377–85.

    Article  PubMed  Google Scholar 

  29. Raina A, Krasinskas AM, Greer JB, et al. Serum immunoglobulin G fraction 4 levels in pancreatic cancer: elevations not associated with autoimmune pancreatitis. Arch Pathol Lab Med. 2008;132:48–53.

    CAS  PubMed  Google Scholar 

  30. Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A, Kamata N. Clinical difficulties in the differentiation of autoimmune pancreatitis and pancreatic carcinoma. Am J Gastroenterol. 2003;98:2694–9.

    Article  PubMed  Google Scholar 

  31. Takahashi N, Fletcher JG, Fidler JL, Hough DM, Kawashima A, Chari ST. Dual-phase CT of autoimmune pancreatitis: a multicenter study. Am J Roentgenol. 2008;190:280–6.

    Article  Google Scholar 

  32. Kamisawa T, Takuma K, Anjiki H, et al. Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI. Am J Gastroenterol. 2010;105:1870–5.

    Article  PubMed  Google Scholar 

  33. Kamisawa T, Imai M, Chen PY, et al. Strategy for differentiating autoimmune pancreatitis from pancreatic cancer. Pancreas. 2008;37:e62–7.

    Article  PubMed  Google Scholar 

  34. Sugumar A, Levy MJ, Kamisawa T, et al. Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicenter study. Gut. 2011;60:666–70.

    Article  PubMed  Google Scholar 

  35. Takuma K, Kamisawa T, Tabata T, Inaba Y, Egawa N, Igarashi Y. Utility of pancreatography for diagnosing autoimmune pancreatitis. World J Gastroenterol. 2011;17:2332–7.

    Article  PubMed Central  PubMed  Google Scholar 

  36. Kamisawa T, Tu Y, Egawa N, et al. Can MRCP replace ERCP for the diagnosis of autoimmune pancreatitis? Abdom Imaging. 2009;34:381–4.

    Article  CAS  PubMed  Google Scholar 

  37. Kamisawa T, Takuma K, Anjiki H, et al. FDG-PET/CT findings of autoimmune pancreatitis. Hepatogastroenterology. 2010;57:447–50.

    PubMed  Google Scholar 

  38. Okazaki K, Kawa S, Kamisawa T, Shimosegawa T, Tanaka M, Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society. Japanese consensus guidelines for management of autoimmune pancreatitis: I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol. 2010;45:249–65.

    Article  PubMed  Google Scholar 

  39. Kamisawa T, Shimosegawa T. Pancreas: Histological diagnostic criteria for autoimmune pancreatitis. Nat Rev Gastroenterol Hepatol. 2011;9:8–10.

    Article  PubMed  Google Scholar 

  40. Kawa S, Okazaki K, Kamisawa T, Shimosegawa T, Tanaka M, Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society. Japanese consensus guidelines for management of autoimmune pancreatitis: II. Extrapancreatic lesions, differential diagnosis. J Gastroenterol. 2010;45:355–69.

    Article  PubMed  Google Scholar 

  41. Kamisawa T, Ohara T, Kim MH, Kanno A, Okazaki K, Fujita N. Role of endoscopy in the diagnosis of autoimmune pancreatitis and IgG4-related sclerosing cholangitis. Dig Endosc. (Epub ahead of print).

    Google Scholar 

  42. Kamisawa T, Tu Y, Egawa N, et al. A new diagnostic endoscopic tool for autoimmune pancreatitis. Gastrointes Endosc. 2008;68:358–61.

    Article  Google Scholar 

  43. Kim MH, Moon SH, Kamisawa T. Major duodenal papilla in autoimmune pancreatitis. Dig Surg. 2010;27:110–4.

    Article  PubMed  Google Scholar 

  44. Kamisawa T, Okazaki K, Kawa S, Shimosegawa T, Tanaka M, Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol. 2010;45:471–7.

    Article  CAS  PubMed  Google Scholar 

  45. Kamisawa T, Okazaki K, Kawa S, et al. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol. 2014;49:961–70.

    Google Scholar 

  46. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706–15.

    Article  PubMed  Google Scholar 

  47. Sandanayake NS, Church NI, Chapman MH, et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol. 2009;7:1089–96.

    Article  CAS  PubMed  Google Scholar 

  48. Hart PA, Topazian MD, Witzig TE, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013;62:1607–15.

    Google Scholar 

  49. Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. (in press).

    Google Scholar 

  50. Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Morphological changes after steroid therapy in autoimmune pancreatitis. Scand J Gastroenterol. 2004;39:1154–8.

    Article  CAS  PubMed  Google Scholar 

  51. Kamisawa T, Notohara K, Shimosegawa T. Two clinicopathologic subtypes of autoimmune pancreatitis: LPSP and IDCP. Gastroenterology. 2010;139:22–5.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

This study was partially supported by the Intractable Disease, supported by the Ministry of Health, Labour, and Welfare of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Terumi Kamisawa MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kamisawa, T., Takeuchi, T., Shiratori, K. (2015). Overview of Type 1 and Type 2 AIP. In: Kamisawa, T., Chung, J. (eds) Autoimmune Pancreatitis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55086-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55086-7_1

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-55085-0

  • Online ISBN: 978-3-642-55086-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics